AI for Pharma & Healthcare 2025

Johnson and Johnson under FBI scanner over possibilities of surgical device power morcellator spread

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Philips, Masimo Extend Partnership to Sensor...

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series...

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
Johnson and Johnson is one of the leading manufacturers of the power morcellator — a surgical device that breaks down growths in the uterus so that they can be easily removed. However, in as many as one out of every 350 cases, an unknown cancer is hidden within growths, and the device could potentially worsen the condition.
Johnson and Johnson may have been alerted to to the risks as early as 2006. The company didn’t remove the device from the market, however, until July 2014. In November of that year, the U.S. Food and Drug Administration implemented its most serious warning on the device.
In that FDA warning, the agency noted that the device could “significantly [worsen] the patient’s long-term survival.”
The agency urged against the use of power morcellators.

 

Latest stories

Related stories

Philips, Masimo Extend Partnership to Sensor Technologies

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series D Funding by JJDC

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »